Source: Annual Congress 2002 - Thoracic oncology: biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Huang, Y. D. Wang, Y. B. Zhu, J. Y. Ma, G. J. Wang, X. G. Zhang (Suzhou, China). The biological features of dendritic cells (DC) induced in malignant pericardial effusion. Eur Respir J 2002; 20: Suppl. 38, 1516

Member's Comments

No comment yet.

Related content which might interest you: Analysis of T-cell subsets in patients with tuberculous pleural effusions Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005 Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006 LSC Abstract – A requirement for mast cells in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 The expression of PD-1 on CD8+ T cells in malignant pleural effusion of lung cancer and its associated significance Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Forced chemokine ligand 2 overexpression renders melanoma cells capable of inducing experimental malignant pleural effusion Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Mast cells recruitment to malignant pleural effusions Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß Source: International Congress 2019 – Biology of lung cancer Year: 2019 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 CD8+ lymphocyte subpopulations in pleural fluid are associated with longer survival in patients with malignant pleural effusion (MPE) submitted to thoracoscopic talc pleurodesis Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002 Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 133-140 Year: 2012 Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 39: 133-140 Year: 2012 Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Interleukin-16 in tuberculous and malignant pleural effusions Source: Eur Respir J 2005; 25: 605-611 Year: 2005 The role of Epithelial sodium channel (ENaC) in cell proliferation and tunneling nanotube (TnT) formation in benign mesothelial cells and malignant pleural mesothelioma (MPM) cells. Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Lymphocyte and lymphocyte subsets in pleural fluid - comparison of malignant and non-malignant disorders Source: Eur Respir J 2002; 20: Suppl. 38, 277s Year: 2002 Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 Utility of significant number of mesothelial cells in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004